Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Colonial First State Managed Investment Funds - Global Health & Biotechnology

+ Add to Watchlist

COLFHLB:AU

2.13 AUD 0.04 1.95%

As of 00:59:30 ET on 03/27/2015.

Snapshot for Colonial First State Managed Investment Funds - Global Health & Biotechnology (COLFHLB)

Year To Date: +13.01% 3-Month: +12.09% 3-Year: +41.42% 52-Week Range: 1.29 - 2.23
1-Month: +0.63% 1-Year: +50.86% 5-Year: +23.60% Beta vs AS51: 0.58

Mutual Fund Chart for COLFHLB

No chart data available.
  • COLFHLB:AU 2.13
  • 1M
  • 1Y
Interactive COLFHLB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for COLFHLB

Colonial First State Mangaged Investment Funds - Global Health & Biotechnology Fund is a unit trust incorporated in Australia. The objective of the Fund is to provide long-term capital growth by predominantly investing in companies around the world, whose primary business is in the fields of pharmaceuticals, biotechnology, medical devices, or medical services.

Inception Date: 04-28-2000 Telephone: 61-2-9303-3000
Managers: DAVID L LEARY
Web Site: www.colonialfirststate.com.au

Fundamentals for COLFHLB

NAV (on 2015-03-27) 2.13
Assets (M) (on 2015-02-27) 26.30
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 0.00

Dividends for COLFHLB

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for COLFHLB

Front Load 4.00
Back Load 0.00
Current Mgmt Fee 2.05
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for COLFHLB

Filing Date: 11/30/2014
Name Position Value % of Total
Bristol-Myers Squibb Co 18,729 1,291,861 6.070%
Actavis plc 3,459 1,100,317 5.170%
Gilead Sciences Inc 9,277 1,093,932 5.140%
Medtronic PLC 9,353 808,743 3.800%
Covidien PLC 6,818 806,615 3.790%
McKesson Corp 3,127 774,691 3.640%
Regeneron Pharmaceuticals Inc 1,427 698,073 3.280%
UnitedHealth Group Inc 5,897 681,047 3.200%
Aetna Inc 5,536 566,120 2.660%
HCA Holdings Inc 6,184 506,529 2.380%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil